DUOXA2: Key Regulator of Cellular Processes and Potential Drug Target Or Biomarker

Target Name: DUOXA2

NCBI ID: G405753

DUOXA2

DUOXA2: Key Regulator of Cellular Processes and Potential Drug Target Or Biomarker

DUOXA2 (DOXA2_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a key regulator of cellular processes in the body and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the biology and significance of DUOXA2, as well as its potential as a drug target or biomarker.

Structure and Function

DUOXA2 is a member of the T-cell receptor (TCR) family, which is responsible for cell signaling and division. The TCR is a transmembrane protein that consists of a variable region and a constant region. The variable region is responsible for recognizing specific antigens, while the constant region contains a tyrosine kinase receptor that is involved in signaling the engagement of antigens.

DUOXA2 is a 21-kDa protein that consists of a variable region and a constant region. The variable region contains a single open reading frame (ORF) that is responsible for encoding the extracellular domain of the protein. The constant region contains a single ORF that is responsible for encoding the cytoplasmic domain of the protein.

DUOXA2 is expressed in a variety of tissues and cells in the body, including the brain, heart, liver, and pancreas. It is highly expressed in the brain, where it is found in the dendrites of neurons and in the cell bodies of astrocytes. It is also expressed in the heart, where it is found in the cardiac muscle cells and in the intercellular junctions of cardiac cells. In the liver, it is found in the hepatocytes and in the pericytes. In the pancreas, it is found in the pancreatic beta cells and in the ductal epithelial cells.

DUOXA2 is involved in a number of cellular processes in the body, including cell signaling, cell division, and apoptosis (programmed cell death). It is a negative regulator of the T-cell receptor and has been shown to play a role in preventing excessive T-cell proliferation. It is also involved in the regulation of cellular processes that are important for tissue growth and development, such as cell migration and the formation of tissues.

DUOXA2 has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of DUOXA2 are associated with poor prognosis in patients with pancreatic cancer. Additionally, research has suggested that DUOXA2 may be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Drug Targeting

DUOXA2 has been shown to be a potential drug target for a number of diseases. One approach to targeting DUOXA2 is to use small molecules that can modulate its activity. For example, several studies have shown that inhibitors of the DUOXA2-TRAF signaling pathway, which is responsible for regulating the activity of DUOXA2, can be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Another approach to targeting DUOXA2 is to use antibodies that can specifically recognize and label it in the body. This approach has been used to study the role of DUOXA2 in various diseases, including cancer and neurodegenerative diseases.

Biomarkers

DUOXA2 has also been used as a biomarker for a number of diseases. For example, studies have shown that DUOXA2 levels are elevated in the brains of patients with Alzheimer's disease, which is associated with increased oxidative stress and inflammation in the brain. Additionally, DUOXA2 has been shown to be elevated in the blood of patients with Parkinson's disease,

Protein Name: Dual Oxidase Maturation Factor 2

Functions: Required for the maturation and the transport from the endoplasmic reticulum to the plasma membrane of functional DUOX2. May play a role in thyroid hormone synthesis

The "DUOXA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUOXA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets